Efflux Pump and Biofilm Inhibitory Activity of Nanoparticles in Acinetobacter Baumannii: a Systematic Review
- PMID: 37844038
- DOI: 10.7754/Clin.Lab.2023.230227
Efflux Pump and Biofilm Inhibitory Activity of Nanoparticles in Acinetobacter Baumannii: a Systematic Review
Abstract
Background: Acinetobacter baumannii produce biofilm and efflux pumps. This systematic review study aimed to provide new strategies to inhibit the efflux pumps and biofilm in A. baumannii using nanoparticles.
Methods: In this research, analyses from 2000 to February 24, 2022, were performed by the Statement of Preferred Reporting Items for Systematic Reviews (PRISMA). Keywords include Acinetobacter baumannii (A. baumannii) AND (biofilm) AND (anti-biofilm activity) AND (nanoparticles) AND (solid lipid NPS) AND (lipid nanocarriers), and in other searches include Acinetobacter baumannii (A. baumanni) AND (efflux pumps) AND (nanoparticles) AND (solid lipid NPS) AND (lipid nanocarriers). Searches were conducted in English databases, including Science Direct, PubMed, Scopus, Ovid, and Cochrane.
Results: At first, 136 studies were extracted, but after removing duplicates, 116 cases remained for further analysis. After evaluating the title and abstract of each study, 95 unrelated studies were excluded. The remaining 25 studies were reviewed based on full texts. Considering the inclusion/exclusion criteria, 19 studies were selected. In this study, metal nanoparticles were the most used nanoparticles for anti-biofilm and efflux pump purposes, and among these nanoparticles, silver nanoparticles (AgNPs) contributed the most.
Conclusions: The present study shows that nanoparticles have potential and significant effects in inhibiting biofilm and efflux pumps in A. baumannii isolates, which researchers can consider in light of the increasing prevalence of antibiotic resistance.
Similar articles
-
Relationship between antibiotic resistance and biofilm-forming capacity with RND efflux pumps expression in clinical Acinetobacter baumannii isolates.Arch Microbiol. 2025 May 25;207(7):153. doi: 10.1007/s00203-025-04347-7. Arch Microbiol. 2025. PMID: 40413665
-
Identification of determinants that allow maintenance of high-level fluoroquinolone resistance in Acinetobacter baumannii.mBio. 2025 Jan 8;16(1):e0322124. doi: 10.1128/mbio.03221-24. Epub 2024 Nov 26. mBio. 2025. PMID: 39589129 Free PMC article.
-
Contribution of RND superfamily multidrug efflux pumps AdeABC, AdeFGH, and AdeIJK to antimicrobial resistance and virulence factors in multidrug-resistant Acinetobacter baumannii AYE.Antimicrob Agents Chemother. 2025 Jul 2;69(7):e0185824. doi: 10.1128/aac.01858-24. Epub 2025 May 23. Antimicrob Agents Chemother. 2025. PMID: 40407309 Free PMC article.
-
A systematic review and meta-analysis for risk factor profiles in patients with resistant Acinetobacter baumannii infection relative to control patients.Int J Risk Saf Med. 2023;34(4):337-355. doi: 10.3233/JRS-220037. Int J Risk Saf Med. 2023. PMID: 37154184
-
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230. doi: 10.1002/14651858.CD001230.pub2. Cochrane Database Syst Rev. 2008. PMID: 18646068
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources